跳至主要内容
临床试验/NCT00539214
NCT00539214已完成不适用

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment

Boehringer Ingelheim1 个研究点 分布在 1 个国家目标入组 1,192 人开始时间: 2007年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,192
试验地点
1
主要终点
Improvement of depressive symptoms (UPDRS item 3, HADS-D) compared to baseline in early and advanced Parkinsons's disease

研究概览

简要总结

  • To compare the effect of pramipexole on depressive symptoms in early and advanced PD patients
  • To evaluate the course of depressive symptoms measured with UPDRS Part I (mentation, behavior and mood) and with HADS-D under pramipexole treatment
  • To investigate whether improvement of depressive symptoms is linked to improvement in motor function (UPDRS Part III)

详细描述

Study Design:

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Improvement of depressive symptoms (UPDRS item 3, HADS-D) compared to baseline in early and advanced Parkinsons's disease

时间窗: 9-16 weeks

Change in sum scores of UPDRS Part III (motor examination) from baseline and UPDRS Part I (mentation, behavior and mood) from baseline

时间窗: 9-16 weeks

Change in HADS subscores (anxiety and depression) from baseline

时间窗: 9-16 weeks

次要结局

  • Baseline pattern of patient rated symptom list (HADS)(9-16 weeks)
  • Correlation of the change in UPDRS Part I and UPDRS Part III at the final visit(9-16 weeks)
  • Frequency of adverse events(9-16 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验